International Edition
Latest News
Business

Boots Ireland Offers Weight Loss Service with Prescriptions & Support

Boots Ireland Expands Weight Loss Services with Prescription Treatments Boots Ireland is now offering a comprehensive weight loss service, combining professional consultations with access to prescription medications. The initiative aims to address the growing issue of overweight and…

Boots Ireland Offers Weight Loss Service with Prescriptions & Support

Boots Ireland Expands Weight Loss Services with Prescription Treatments

Boots Ireland is now offering a comprehensive weight loss service, combining professional consultations with access to prescription medications. The initiative aims to address the growing issue of overweight and obesity in Ireland, where over 60% of adults are affected, increasing their risk of heart disease, diabetes and stroke .

Service Details and Eligibility

The Boots weight loss service is designed for adults with a Body Mass Index (BMI) of 30 kg/m² or higher. Individuals with weight-related health conditions, such as diabetes, high blood pressure, or breathing problems, may also be eligible with a lower BMI threshold of 27 kg/m² . The process begins with a consultation, either with a General Practitioner (GP) or through online services.

Following the initial consultation, a 10-minute in-store Weight Check Consultation is conducted by a trained healthcare professional. This assessment includes measuring BMI, waist circumference, and blood pressure, and provides personalized advice. If deemed appropriate, a prescription medication can be provided and collected at the same time .

Ongoing pharmacy weight checks are scheduled as recommended by the doctor to support patients in maintaining their progress. Boots emphasizes the importance of consistency and provides follow-up appointments to ensure patients receive the necessary guidance for sustainable results .

Available Prescription Medications

Boots Ireland offers several prescription weight loss treatments, including:

  • Mounjaro: A weekly injectable pen containing tirzepatide, which regulates blood sugar and energy balance, reducing appetite and cravings . Pricing for a single pen ranges from £176.97 to £334.97 depending on the dosage (2.5mg to 15mg) .
  • Wegovy: A once-weekly self-injection containing semaglutide, which controls appetite and reduces food cravings. It’s intended for sustained weight loss alongside a reduced-calorie diet and increased physical activity. Semaglutide has also been shown to reduce the risk of heart attack and stroke in adults with heart disease . A single pen costs between £99.97 and £205.97, with a 3-pack of 2.4mg pens available for £285 .
  • Orlistat and Xenical: These medications reduce fat absorption in the digestive system .

To continue medication after 12 weeks, patients must demonstrate at least a 5% loss of their initial body weight . Boots provides sharps disposal bins and consultations at no extra charge when recommended .

Additional Support and Resources

Boots provides a 360° support system, including a podcast, live webinars, a 10-week program, exercise videos, a 12-month aftercare plan, and a tracker app to support patients maintain consistency and achieve their weight loss goals .

About the author: Marcus Liu - Business Editor

MBA and ex‑B bureau chief specializing in global finance and fintech. Marcus speaks Mandarin, Japanese, and English, and has interviewed CEOs from the Fortune 50 to Y‑Combinator unicorns. Marcus Liu delivers sharp analysis on markets, startups, and corporate strategy for investors and entrepreneurs alike.